4.5 Review

Combinatorial chemistry in drug discovery

期刊

CURRENT OPINION IN CHEMICAL BIOLOGY
卷 38, 期 -, 页码 117-126

出版社

ELSEVIER SCI LTD
DOI: 10.1016/j.cbpa.2017.03.017

关键词

-

资金

  1. National Institutes of Health [R21 CA135345, R01CA115483, R33CA196445, U01EB021230]

向作者/读者索取更多资源

Several combinatorial methods have been developed to create focused or diverse chemical libraries with a wide range of linear or macrocyclic chemical molecules: peptides, non-peptide oligomers, peptidomimetics, small-molecules, and natural product-like organic molecules. Each combinatorial approach has its own unique high-throughput screening and encoding strategy. In this article, we provide a brief overview of combinatorial chemistry in drug discovery with emphasis on recently developed new technologies for design, synthesis, screening and decoding of combinatorial library. Examples of successful application of combinatorial chemistry in hit discovery and lead optimization are given. The limitations and strengths of combinatorial chemistry are also briefly discussed. We are now in a better position to truly leverage the power of combinatorial technologies for the discovery and development of next-generation drugs.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据